Target intelligence / Profile preview

Pyroglutamyl-peptidase I (PGPEP1)

Target
PGPEP1
Molecular classification
Enzyme, Cysteine protease, Peptidase (C15 family)
01

Overview

Pyroglutamyl-peptidase I (PGPEP1) is a cytosolic cysteine protease belonging to the peptidase C15 family, found in humans and widely across species. This enzyme selectively cleaves N-terminal pyroglutamate (pGlu) residues from bioactive peptides and proteins, including several hypothalamic hormones such as thyrotropin-releasing hormone (TRH) and luteinizing hormone-releasing hormone (LH-RH), which are otherwise resistant to degradation by conventional aminopeptidases. By regulating the removal of pGlu residues, Pyroglutamyl-peptidase I plays a role in hormone inactivation, peptide turnover, and potentially nutrient assimilation, primarily in lower organisms. The enzyme is characterized by a catalytic triad (Cys-His-Asp/Glu) and does not conform to the typical oxyanion hole seen in many cysteine proteases. Its expression and activity are altered in various disease conditions, and it is being studied for roles in cancer biology and male infertility as well as a general marker of peptide metabolism.

Other names
Pyroglutamyl-peptidase 1PGPIPAP-IPGP-IPcpPGP5-oxoprolyl-peptidasePyroglutamyl aminopeptidase IPyrrolidone-carboxylate peptidasePYRase2810003H13RIKGm19458LOC100502927MGC10812
02

Mechanism of action

Proteolytic removal of N-terminal pyroglutamyl residue via catalytic triad (Cys-His-Asp/Glu)

03

Biological functions

Cleavage of N-terminal pyroglutamate (pGlu) residues from peptidesRegulation of peptide hormone inactivation (e.g., thyrotropin-releasing hormone, luteinizing hormone-releasing hormone)Peptide turnover and possible nutrient assimilation (primarily in prokaryotes)
04

Disease associations

Cancer (correlation with progression in colorectal cancer; downregulation observed)Liver disease (decreased activity in liver cirrhosis)Male infertility (elevated activity in necrozoospermia)Olecranon bursitis
05

Biomarkers

Downregulation may be a biomarker for colorectal cancer progression

Beyond the preview

Go deeper on Pyroglutamyl-peptidase I (PGPEP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyroglutamyl-peptidase I (PGPEP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call